Primary pulmonary hypertension: a look at the future.

[1]  C. Hales,et al.  Impairment of hypoxic pulmonary artery remodeling by heparin in mice. , 2015, The American review of respiratory disease.

[2]  Julie H. Campbell,et al.  Potential Role of Heparanase in Atherosclerosis , 1989 .

[3]  N. Voelkel,et al.  Charge-related lung microvascular injury. , 1989, The American review of respiratory disease.

[4]  P. Davies.  How Do Vascular Endothelial Cells Respond to Flow , 1989 .

[5]  R. Virmani,et al.  Heterogeneity of pathologic lesions in familial primary pulmonary hypertension. , 1988, The American review of respiratory disease.

[6]  T. Driscol,et al.  Primary pulmonary hypertension in patients with classic hemophilia. , 1988, Annals of internal medicine.

[7]  J. Hoidal,et al.  Reperfusion injury occurs in the lung by free radical mechanisms. , 1988, Chest.

[8]  S. Archer,et al.  Chronic primary and secondary thromboembolic pulmonary hypertension. , 1988, Chest.

[9]  W. Edwards,et al.  Coexistent pulmonary and portal hypertension: morphologic and clinical features. , 1987, Journal of the American College of Cardiology.

[10]  D. Buff.  Primary pulmonary hypertension. , 1987, Annals of internal medicine.

[11]  E Ruoslahti,et al.  New perspectives in cell adhesion: RGD and integrins. , 1987, Science.

[12]  P. Shah,et al.  Prostaglandin E1 as a screening vasodilator in primary pulmonary hypertension. , 1987, Chest.

[13]  B. Groves,et al.  PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDY , 1987 .

[14]  R. Mecham,et al.  Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. , 1987, Science.

[15]  B. Brundage,et al.  High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. , 1987, Circulation.

[16]  G. Pietra,et al.  Specificity of pulmonary vascular lesions in primary pulmonary hypertension. A reappraisal. , 1987, Respiration; international review of thoracic diseases.

[17]  M. Pepi,et al.  Hypersensitivity of lung vessels to catecholamines in systemic hypertension. , 1986, British medical journal.

[18]  L. Rubin,et al.  Primary Pulmonary Hypertension: AN ANALYSIS OF 28 CASES AND A REVIEW OF THE LITERATURE , 1986 .

[19]  S. Moore,et al.  Pathogenesis of atherosclerosis. , 1985, Metabolism: clinical and experimental.

[20]  J. Seward,et al.  Doppler echocardiography: theory, instrumentation, technique, and application. , 1985, Mayo Clinic proceedings.

[21]  T. Higenbottam,et al.  LONG-TERM TREATMENT OF PRIMARY PULMONARY HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN) , 1984, The Lancet.

[22]  P. D. de Feyter,et al.  Sustained beneficial effect of nifedipine in primary pulmonary hypertension. , 1983, American heart journal.

[23]  J. G. Douglas,et al.  Pulmonary hypertension and fenfluramine , 1981, British medical journal.

[24]  D. Heath,et al.  Small pulmonary arteries in some natives of La Paz, Bolivia. , 1981, Thorax.

[25]  M. Kahaleh,et al.  Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. , 1981, Annals of internal medicine.

[26]  Richard J. Jones.  Heart Disease: A Textbook of Cardiovascular Medicine , 1980 .

[27]  R. Peter,et al.  Oral hydralazine therapy for primary pulmonary hypertension. , 1980, The New England journal of medicine.

[28]  V. Maranhao,et al.  Phentolamine for primary pulmonary hypertension. , 1979, Annals of internal medicine.

[29]  L. Dolman.  Cyproheptadine effects on pituitary function. , 1979, Annals of internal medicine.

[30]  R. C. Franz,et al.  A possible causal relationship between defective fibrinolysis and pulmonary hypertension. , 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[31]  J. Reeves,et al.  Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. , 1978, The American journal of cardiology.

[32]  W. Edwards,et al.  Clinical primary pulmonary hypertension: three pathologic types. , 1977, Circulation.

[33]  J. LeónCastro,et al.  [Primary pulmonary hypertension]. , 1971, Revista clinica espanola.

[34]  C. Wagenvoort,et al.  Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .

[35]  J. Edwards,et al.  The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects , 1958, Circulation.

[36]  D. Heath,et al.  Hypertensive Pulmonary Vascular Disease , 1956, Circulation.

[37]  D. Dresdale,et al.  Primary pulmonary hypertension. I. Clinical and hemodynamic study. , 1951, The American journal of medicine.

[38]  V. Fuster,et al.  Regression in thromboembolic type of primary pulmonary hypertension during 2 1/2 years of antithrombotic therapy. , 1986, Journal of the American College of Cardiology.

[39]  R. Mellins,et al.  Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child. , 1985, The American review of respiratory disease.

[40]  J. Newman,et al.  Familial primary pulmonary hypertension: clinical patterns. , 1984, The American review of respiratory disease.

[41]  thle Ldnabtftu,et al.  The pathogenesis of atherosclerosis. , 1979, Mechanisms of ageing and development.

[42]  K. Vonkaulla.  LIVER IN REGULATION OF FIBRINOLYTIC ACTIVITY. , 1964, Lancet.